These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
220 related items for PubMed ID: 18083060
1. Inflammatory cytokines and dendritic cells in acute graft-versus-host disease after allogeneic stem cell transplantation. Mohty M, Gaugler B. Cytokine Growth Factor Rev; 2008 Feb; 19(1):53-63. PubMed ID: 18083060 [Abstract] [Full Text] [Related]
2. Dendritic cells and acute graft-versus-host disease after allogeneic stem cell transplantation. Mohty M. Leuk Lymphoma; 2007 Sep; 48(9):1696-701. PubMed ID: 17786704 [Abstract] [Full Text] [Related]
3. Reduced intensity conditioning for allogeneic hematopoietic stem-cell transplant determines the kinetics of acute graft-versus-host disease. Turner BE, Kambouris ME, Sinfield L, Lange J, Burns AM, Lourie R, Atkinson K, Hart DN, Munster DJ, Rice AM. Transplantation; 2008 Oct 15; 86(7):968-76. PubMed ID: 18852664 [Abstract] [Full Text] [Related]
4. The role of endotoxin and the innate immune response in the pathophysiology of acute graft versus host disease. Cooke KR, Olkiewicz K, Erickson N, Ferrara JL. J Endotoxin Res; 2002 Oct 15; 8(6):441-8. PubMed ID: 12697087 [Abstract] [Full Text] [Related]
5. Bone marrow-derived mesenchymal stem cells decrease acute graft-versus-host disease after allogeneic hematopoietic stem cells transplantation. Tian Y, Deng YB, Huang YJ, Wang Y. Immunol Invest; 2008 Oct 15; 37(1):29-42. PubMed ID: 18214798 [Abstract] [Full Text] [Related]
6. The pathophysiology of acute graft-versus-host disease. Jaksch M, Mattsson J. Scand J Immunol; 2005 May 15; 61(5):398-409. PubMed ID: 15882431 [Abstract] [Full Text] [Related]
9. Immunopathogenesis of acute graft-versus-host disease: implications for novel preventive and therapeutic strategies. Zeiser R, Marks R, Bertz H, Finke J. Ann Hematol; 2004 Sep 15; 83(9):551-65. PubMed ID: 15449032 [Abstract] [Full Text] [Related]
10. Induction of lethal graft-versus-host disease by anti-CD137 monoclonal antibody in mice prone to chronic graft-versus-host disease. Kim W, Kim J, Jung D, Kim H, Choi HJ, Cho HR, Kwon B. Biol Blood Marrow Transplant; 2009 Mar 15; 15(3):306-14. PubMed ID: 19203721 [Abstract] [Full Text] [Related]
11. Biological advances in acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation. Duran-Struuck R, Reddy P. Transplantation; 2008 Feb 15; 85(3):303-8. PubMed ID: 18301323 [Abstract] [Full Text] [Related]
12. Pathophysiology of acute graft-versus-host disease. Reddy P. Hematol Oncol; 2003 Dec 15; 21(4):149-61. PubMed ID: 14735553 [Abstract] [Full Text] [Related]
13. A possible role for CCL27/CTACK-CCR10 interaction in recruiting CD4 T cells to skin in human graft-versus-host disease. Faaij CM, Lankester AC, Spierings E, Hoogeboom M, Bowman EP, Bierings M, Révész T, Egeler RM, van Tol MJ, Annels NE. Br J Haematol; 2006 Jun 15; 133(5):538-49. PubMed ID: 16681643 [Abstract] [Full Text] [Related]
15. Expanded donor natural killer cell and IL-2, IL-15 treatment efficacy in allogeneic hematopoietic stem cell transplantation. Chen G, Wu D, Wang Y, Cen J, Feng Y, Sun A, Tang X, Chang H, Zhu Z. Eur J Haematol; 2008 Sep 15; 81(3):226-35. PubMed ID: 18573173 [Abstract] [Full Text] [Related]
16. [Graft vs host disease]. Moalic V, Ferec C. Pathol Biol (Paris); 2006 May 15; 54(5):304-8. PubMed ID: 16530350 [Abstract] [Full Text] [Related]
17. The initial phase of graft-versus-host disease is associated with a decrease of CD4+CD25+ regulatory T cells in the peripheral blood of patients after allogeneic stem cell transplantation. Schneider M, Munder M, Karakhanova S, Ho AD, Goerner M. Clin Lab Haematol; 2006 Dec 15; 28(6):382-90. PubMed ID: 17105491 [Abstract] [Full Text] [Related]